| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.26 | 0.01 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.29 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |